Phio Pharmaceuticals Corp. - ROE
PHIO
Price:
$1.07
Market Cap:
$12.43M
Phio Pharmaceuticals Corp., a clinical stage biopharmaceutical company, engages in the development of immuno-oncology therapeutics in the United States. It develops PH-762, an INTASYL compound designed to reduce the expression of PD-1 in multi-center Phase 1b dose-escalating clinical trials; PH-894, an INTASYL compound that is designed to specifically silence BRD4, a protein that controls gene expression in both T cells and tumor cells in preclinical studies. The company was formerly known as RXi Pharmaceuticals Corporation and changed its name to Phio Pharmaceuticals Corp. in November 2018. Phio Pharmaceuticals Corp. was founded in 2003 and is based in King Of Prussia, Pennsylvania.
Industry
Biotechnology
IPO Date
2012-05-10
Stock Exchange
NASDAQ
Ticker
PHIO
PE Ratio
[-0.78]
ROE
[-77.34%]
Current Ratio
[66.93]
Dividend Yield
[0%]
Enterprise Value
[-4600542.00]
Dividend History
The ROE as of August 2026 (TTM) for Phio Pharmaceuticals Corp. (PHIO) is -77.34%
According to Phio Pharmaceuticals Corp.’s latest financial reports and current stock price. The company's current ROE is -77.34%. This represents a change of 277.93% compared to the average of -20.46% of the last 4 quarters.
Phio Pharmaceuticals Corp. (PHIO) Historical ROE (quarterly & annually)
How has PHIO ROE performed in the past?
The mean historical ROE of Phio Pharmaceuticals Corp. over the last ten years is -154.00%. The current -77.34% ROE has changed -49.78% with respect to the historical average. Over the past ten years (40 quarters), PHIO's ROE was at its highest in in the June 2021 quarter at -9.32%. The ROE was at its lowest in in the March 2018 quarter at -394.89%.
Average
-154.00%
Median
-94.38%
Minimum
-679.32%
Maximum
-43.17%
Phio Pharmaceuticals Corp. (PHIO) ROE by Quarter and Year
Discovering the peaks and valleys of Phio Pharmaceuticals Corp. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 719.89%
Maximum Annual ROE = -43.17%
Minimum Annual Increase = -92.02%
Minimum Annual ROE = -679.32%
| Year | ROE | Change |
|---|---|---|
| 2025 | -43.17% | -71.48% |
| 2024 | -151.39% | 8.09% |
| 2023 | -140.05% | 32.24% |
| 2022 | -105.90% | 74.81% |
| 2021 | -60.58% | -10.32% |
| 2020 | -67.56% | -56.41% |
| 2019 | -154.98% | 185.90% |
| 2018 | -54.21% | -92.02% |
| 2017 | -679.32% | 719.89% |
| 2016 | -82.86% | -27.95% |
Phio Pharmaceuticals Corp. (PHIO) Average ROE
How has PHIO ROE performed in the past?
The current ROE of Phio Pharmaceuticals Corp. (PHIO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-111.54%
5-year avg
-100.22%
10-year avg
-154.00%
Phio Pharmaceuticals Corp. (PHIO) ROE vs. Peers
How is PHIO’s ROE compared to its peers?
Phio Pharmaceuticals Corp.’s ROE is greater than TransCode Therapeutics, Inc. (-99.39%), greater than Kiora Pharmaceuticals, Inc. (-59.30%), greater than IN8bio, Inc. (-96.39%), greater than BioCardia, Inc. (-5456.14%), greater than Aprea Therapeutics, Inc. (-59.54%), greater than Marker Therapeutics, Inc. (-73.29%), greater than Damora Therapeutics, Inc. (-122.61%), greater than Creative Medical Technology Holdings, Inc. (-88.50%), greater than Acurx Pharmaceuticals, Inc. (-153.93%), greater than Aptevo Therapeutics Inc. (-198.50%),
| Company | ROE | Market cap |
|---|---|---|
| -99.39% | $4.50M | |
| -59.30% | $11.26M | |
| -96.39% | $9.48M | |
| -5456.14% | $5.51M | |
| -59.54% | $4.03M | |
| -73.29% | $12.31M | |
| -122.61% | $34.47M | |
| -88.50% | $1.76M | |
| -153.93% | $2.33M | |
| -198.50% | $9.16M |
Build a custom stock screener for Phio Pharmaceuticals Corp. (PHIO) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Phio Pharmaceuticals Corp. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Phio Pharmaceuticals Corp. (PHIO) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Phio Pharmaceuticals Corp. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Phio Pharmaceuticals Corp.'s ROE?
How is the ROE calculated for Phio Pharmaceuticals Corp. (PHIO)?
What is the highest ROE for Phio Pharmaceuticals Corp. (PHIO)?
What is the 3-year average ROE for Phio Pharmaceuticals Corp. (PHIO)?
What is the 5-year average ROE for Phio Pharmaceuticals Corp. (PHIO)?
How does the current ROE for Phio Pharmaceuticals Corp. (PHIO) compare to its historical average?